Institution statistics

ASTRAZENECA AB - Sweden 

This institution has been merged with: ASTRAZENECA.

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:68
Total Project Funding:500-600
Partner Constancy:51
Project Leadership Index:69
Diversity Index:64
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:800-900
Total Number of Projects:900-1000
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:600-700
Total Number of Projects:800-900
Total Project Funding:500-600
Networking Rank (Reputation):700-800
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2009
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:400-500
Project Leadership Index:> 1000
Diversity Index:200-300
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 48
As coordinator: 1
As participant: 47
Sole participant: 0
Coordinator / Participant Ratio: 0.02*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 12.308.542 281.983 2
2018 0 34.105.743 0 3
2017 0 66.648.068 527.319 7
2016 0 37.769.192 2.021.388 9
2015 0 10.088.161 666.784 3
2014 0 3.301.294 232.272 1
2013 0 21.428.778 2.163.015 6
2012 0 4.165.299 202.078 1
2011 0 8.609.001 473.035 2
2010 0 5.791.918 364.670 2
2008 0 30.774.393 1.984.363 5
2006 0 17.220.107 1.011.256 3
2005 0 11.998.527 285.679 1
2004 0 4.850.000 285.294 1
2001 1.555.000 1.411.000 529.850 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV10
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE9
ELI LILLY AND COMPANY LIMITED7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
KAROLINSKA INSTITUTE7
NOVARTIS PHARMA7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH6
PFIZER LIMITED6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
BAYER AKTIENGESELLSCHAFT5
F HOFFMANNLA ROCHE5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
GOETEBORGS UNIVERSITET5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
SANOFIAVENTIS DEUTSCHLAND5
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT5
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL5
UNIVERSITAET BERN5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER4
UCB BIOPHARMA4
UNIVERSITY OF COPENHAGEN4
UPPSALA UNIVERSITET4
ABBVIE INC3
ACADEMISCH ZIEKENHUIS GRONINGEN3
ACADEMISCH ZIEKENHUIS LEIDEN3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EUROPEAN PATIENTS' FORUM3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
HEINRICHHEINEUNIVERSITAET DUESSELDORF3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
NOVO NORDISK3
RIJKSUNIVERSITEIT GRONINGEN3
STOCKHOLMS UNIVERSITET3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSIDADE DE AVEIRO3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITE VICTOR SEGALEN BORDEAUX II3
UNIVERSITEIT LEIDEN3
UNIVERSITY OF LEEDS3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIWERSYTET JAGIELLONSKI3
AARHUS UNIVERSITETSHOSPITAL2
ABBVIE DEUTSCHLAND GMBH & CO KG2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ALZHEIMER EUROPE2
AMGEN LIMITED2
ASTELLAS PHARMA EUROPE BV2
BAYER PHARMA2
CELLARTIS AB2
CERTARA UK LIMITED2
CHALMERS TEKNISKA HOEGSKOLA AB2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV2
ENAMINE LIMITED LIABILITY COMPANYRESEARCH AND PRODUCTION ENTERPRISE2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN SYNCHROTRON RADIATION FACILITY2
FUNDACIO IMIM2
GIOTTO BIOTECH2
GLAXOSMITHKLINE BIOLOGICALS2
INSTITUT PASTEUR2
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS2
KAROLINSKA INSTITUTET2
KING'S COLLEGE LONDON2
KLINIKUM DER UNIVERSITAET ZU KOELN2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LEAD DISCOVERY CENTER2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE2
MERCK SHARP & DOHME CORP2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
ORION OYJ2
POLITECNICO DI MILANO2
REGION HOVEDSTADEN2
SANOFI PASTEUR2
SP SWEDISH NATIONAL TESTING AND RESEARCH INSTITUTE2
ST GEORGE'S HOSPITAL MEDICAL SCHOOL2
STATENS SERUM INSTITUT2
STICHTING VUMC2
TAROS CHEMICALS GMBH & CO KG2
TECHNISCHE UNIVERSITAET MUENCHEN2
TECHNISCHE UNIVERSITEIT EINDHOVEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF NOTTINGHAM2
UCB BIOPHARMA SPRL2
UCB PHARMA2
Constancy:

Total number of partners:737

Partner loyalty:
Frequent Partner: (> 2 projects): 229
Rare Partner: 508

Frequent / Rare Partner Ratio: 0.45

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES17
RTD HORIZONTAL TOPICS9
INDUSTRY AND TECHNOLOGY8
SOCIAL AND ECONOMIC CONCERNS7
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69428
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Improving Genome Editing Efficiency (IMGENE) IMGENEparticipant2.068.40910
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-01-01Molecular Tools for Nucleic Acid Manipulation for Biological Intervention MMBioparticipant3.971.34819
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-06-01PET Imaging in Drug Design and Development PET3Dparticipant3.901.24810
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2016-01-01Non-Noble Metal Catalysis - NoNoMeCat NoNoMeCatparticipant3.318.63415
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2016-01-01Accelerated Early staGe drug diScovery AEGISparticipant3.836.99626
2015-11-01Synaptic Dysfunction in Alzheimer Disease SyDADparticipant3.846.73611
2015-09-01Exascale Compound Activity Prediction Engine ExCAPEparticipant3.910.1409
2015-01-01Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics X-probeparticipant2.331.2859
2014-03-01"FLUOR21 : Synthesis, structure and function of fluorinated systems" FLUOR21participant3.301.2949
2013-10-01Phylogenetic exploration of medicinal plant diversity MEDPLANTparticipant4.231.60510
2013-10-01Female Investigators in Nonlinear Optical Nanoscopy - FINON FINONparticipant3.470.6526
2013-10-01Identification and validation of novel pharmaceutical drug targets for cardiovascular disease CARTARDISparticipant5.973.52113
2013-01-01Innovative Modelling for Pharmacological Advances through Collaborative Training IMPACTparticipant1.467.9582
2013-01-01Pushing the Envelope of Nuclear Magnetic Resonance Spectroscopy for Paramagnetic Systems. A Combined Experimental and Theoretical Approach PNMRparticipant3.470.41312
2013-01-01Membrane Protein Nanocrystallography NANOMEMparticipant2.814.62910
2012-01-01Development of Cytochrome P450 Enzymes for the Chemical Manufacturing Industries P4FIFTYparticipant4.165.29910
2011-03-01Integrating research training in particle & powder technology to deliver efficient products with high functionality PowTechparticipant3.909.00115
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXparticipant4.700.00015
2010-11-01Pulmonary Imaging Network π-netparticipant3.043.59910
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920
2008-06-01Integrated synthesis and purification of single enantiomers INTENANTparticipant3.693.40011
2008-04-01Large Scale Semantic Computing\nSemantic Web technologies\ndistributed reasoning\nprobabilistic reasoning\nweb-scale inference\ninformation retrieval LarKCparticipant7.703.29319
2008-02-01European drug initiative on channels and transporters EDICTparticipant11.896.55728
2008-02-01Exploring and understanding adverse drug reactions by integrative mining of clinical records and biomedical knowledge EU-ADRparticipant4.500.00014
2008-01-01COPD pathology: addressing critical gaps, early treatment and innovative concepts COPACETICparticipant2.981.1436
2006-01-01New medicines for tuberculosis NM4TBparticipant11.070.00022
2006-01-01Reducing animal experimentation in pre-clinical predictive drug testing by human hepatic in vitro models derived from embryonic stem cells VITROCELLOMICSparticipant2.942.00010
2006-01-01Dynamic interactive chemical biology and biomedicine DYNAMICparticipant3.208.10715
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
2004-01-01Structuring European Biomedical Informatics to Support Individualised Healthcare INFOBIOMEDparticipant4.850.00017
2001-02-01Linking Organisations Through a Secure Environment for Distributed Drug Discovery LINK3Dparticipant1.411.00010
2001-01-01Voluntary Industrial Code of Practice for IST-enabled work across national borders VIPcoordinator1.555.0004
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum